Patent application number | Description | Published |
20090192140 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: | 07-30-2009 |
20100203012 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed herein is a compound of Formula 1: | 08-12-2010 |
20100221261 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II | 09-02-2010 |
20100292269 | BIR DOMAIN BINDING COMPOUNDS - The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: | 11-18-2010 |
20110117081 | FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS - A compound of Formula (1) or a salt thereof, methods for the preparation and use of such a compound, especially as an IAP inhibitor, and related compounds, compositions, and methods. | 05-19-2011 |
20110171171 | BRIDGED SECONDARY AMINES AND USE THEREOF AS IAP BIR DOMAIN BINDING COMPOUNDS - A compound of Formula 1.1A: 1.1A or salt thereof, as well as methods of making compounds of Formula 1.1A, methods of using compounds of Formula 1.1A to treat proliferative disorders such as cancer, and related compounds, composition, and methods. | 07-14-2011 |
20120009141 | FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS - A compound of Formula 1: or a salt thereof, and methods for the use thereof, especially as an IAP inhibitor, as well as related compounds, compositions, and methods. | 01-12-2012 |
20120141496 | IAP BIR DOMAIN BINDING COMPOUNDS - The present invention, according to several embodiments, comprises a compound represented by Formula I: | 06-07-2012 |
20120195915 | IAP BIR domain binding compounds - Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: | 08-02-2012 |
20130040892 | IAP BIR DOMAIN BINDING COMPOUNDS - A compound of Formula 1: (I) or salt thereof, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods. | 02-14-2013 |
20130071411 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II | 03-21-2013 |
20140045833 | Protein Kinase Inhibitors - The present invention relates to a novel family of inhibitors of protein kinases of Formula (1) wherein X is selected from CH2, O, S(0)n, or NR6; and process for their production and pharmaceutical compositions thereof. In particular, the present invention relates to inhibitors of the members of the Tec, Src, Btk and Lck protein kinase families. | 02-13-2014 |
20140336134 | IAP BIR Domain Binding Compounds - A compound of Formula I | 11-13-2014 |